Here's how BIOMEDCENTRAL.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

BIOMEDCENTRAL . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Biomedcentral.com Make Money
  6. How Much Does Biomedcentral.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers

We began analyzing https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-10-598/peer-review, but it redirected us to https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-10-598/peer-review. The analysis below is for the second page.

Title[redir]:
Role of 14-3-3Οƒ in poor prognosis and in radiation and drug resistance of human pancreatic cancers | BMC Cancer | Peer Review
Description:
Pancreatic cancer is the fourth leading cause of death in the US. Unlike other solid tumors such as testicular cancer which are now curable, more than 90% of pancreatic cancer patients die due to lack of response to therapy. Recently, the level of 14-3-3Οƒ mRNA was found to be increased in pancreatic cancers and this increased expression may contribute to the failure in treatment of pancreatic cancers. In the present study, we tested this hypothesis. Western blot analysis was used to determine 14-3-3Οƒ protein level in fresh frozen tissues and was correlated to clinical outcome. A stable cell line expressing 14-3-3Οƒ was established and the effect of 14-3-3Οƒ over-expression on cellular response to radiation and anticancer drugs were tested using SRB assay and clonogenic assays. Cell cycle distribution and apoptosis analyses were performed using propidium iodide staining and PARP cleavage assays. We found that 14-3-3Οƒ protein level was increased significantly in about 71% (17 of 24) of human pancreatic cancer tissues and that the 14-3-3Οƒ protein level in cancers correlated with lymph node metastasis and poor prognosis. Furthermore, we demonstrated that over-expression of 14-3-3Οƒ in a pancreatic cancer cell line caused resistance to Ξ³-irradiation as well as anticancer drugs by causing resistance to treatment-induced apoptosis and G2/M arrest. The increased level of 14-3-3Οƒ protein likely contributes to the poor clinical outcome of human pancreatic cancers by causing resistance to radiation and anticancer drugs. Thus, 14-3-3Οƒ may serve as a prognosis marker predicting survival of pancreatic cancer patients and guide the clinical treatment of these patients.

Matching Content Categories {πŸ“š}

  • Science
  • Social Networks
  • Health & Fitness

Content Management System {πŸ“}

What CMS is biomedcentral.com built with?

Custom-built

No common CMS systems were detected on Biomedcentral.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of biomedcentral.com audience?

πŸš€ Good Traffic: 50k - 100k visitors per month


Based on our best estimate, this website will receive around 50,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Biomedcentral.com Make Money? {πŸ’Έ}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (3)
yourbow.com, google.com, doceree.com

How Much Does Biomedcentral.com Make? {πŸ’°}


Display Ads {🎯}

$690 per month
Our estimates place Biomedcentral.com's monthly online earnings from display ads at $462 to $1,271.

Keywords {πŸ”}

bmc, cookies, author, version, privacy, manuscript, submitted, reviewed, reviewer, report, page, data, information, submission, responded, comments, jianting, zhang, resubmission, sep, oct, article, optional, content, personal, parties, policy, manage, published, cancer, peer, review, original, jul, guenter, schneider, aaron, spalding, aug, nov, contact, enquiries, editing, authors, choice, essential, make, site, function, advertising,

Topics {βœ’οΈ}

authors scientific editing privacy choices/manage cookies bmc european economic area state privacy rights accepting optional cookies peer review 1471-2407 contact manage preferences author responded article published submission enquiries personal data optional cookies data protection essential cookies cookies skip cookies policy privacy policy privacy statement usage analysis social media varying standards poor prognosis drug resistance editorially accepted general enquiries preference centre springer nature content choices 1 nov 2010 privacy published choice make site function advertising personalisation consent processing parties information change accept role 14-3-3Οƒ radiation submitted

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Role of 14-3-3Οƒ in poor prognosis and in radiation and drug resistance of human pancreatic cancers
         description:Pancreatic cancer is the fourth leading cause of death in the US. Unlike other solid tumors such as testicular cancer which are now curable, more than 90% of pancreatic cancer patients die due to lack of response to therapy. Recently, the level of 14-3-3Οƒ mRNA was found to be increased in pancreatic cancers and this increased expression may contribute to the failure in treatment of pancreatic cancers. In the present study, we tested this hypothesis. Western blot analysis was used to determine 14-3-3Οƒ protein level in fresh frozen tissues and was correlated to clinical outcome. A stable cell line expressing 14-3-3Οƒ was established and the effect of 14-3-3Οƒ over-expression on cellular response to radiation and anticancer drugs were tested using SRB assay and clonogenic assays. Cell cycle distribution and apoptosis analyses were performed using propidium iodide staining and PARP cleavage assays. We found that 14-3-3Οƒ protein level was increased significantly in about 71% (17 of 24) of human pancreatic cancer tissues and that the 14-3-3Οƒ protein level in cancers correlated with lymph node metastasis and poor prognosis. Furthermore, we demonstrated that over-expression of 14-3-3Οƒ in a pancreatic cancer cell line caused resistance to Ξ³-irradiation as well as anticancer drugs by causing resistance to treatment-induced apoptosis and G2/M arrest. The increased level of 14-3-3Οƒ protein likely contributes to the poor clinical outcome of human pancreatic cancers by causing resistance to radiation and anticancer drugs. Thus, 14-3-3Οƒ may serve as a prognosis marker predicting survival of pancreatic cancer patients and guide the clinical treatment of these patients.
         datePublished:2010-11-01T00:00:00Z
         dateModified:2010-11-01T00:00:00Z
         pageStart:1
         pageEnd:11
         license:https://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1471-2407-10-598
         keywords:
            Pancreatic Cancer
            Gemcitabine
            Pancreatic Cancer Cell
            Mitoxantrone
            Human Pancreatic Cancer
            Cancer Research
            Oncology
            Surgical Oncology
            Health Promotion and Disease Prevention
            Biomedicine
            general
            Medicine/Public Health
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-598/MediaObjects/12885_2010_Article_2397_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-598/MediaObjects/12885_2010_Article_2397_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-598/MediaObjects/12885_2010_Article_2397_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-598/MediaObjects/12885_2010_Article_2397_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-598/MediaObjects/12885_2010_Article_2397_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-598/MediaObjects/12885_2010_Article_2397_Fig6_HTML.jpg
         isPartOf:
            name:BMC Cancer
            issn:
               1471-2407
            volumeNumber:10
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Zhaomin Li
               affiliation:
                     name:Indiana University School of Medicine
                     address:
                        name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zizheng Dong
               affiliation:
                     name:Indiana University School of Medicine
                     address:
                        name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David Myer
               affiliation:
                     name:Indiana University School of Medicine
                     address:
                        name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michele Yip-Schneider
               affiliation:
                     name:Indiana University School of Medicine
                     address:
                        name:Department of Surgery, Indiana University School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
                     name:Indiana University School of Medicine
                     address:
                        name:IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jianguo Liu
               affiliation:
                     name:Indiana University School of Medicine
                     address:
                        name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ping Cui
               affiliation:
                     name:Indiana University School of Medicine
                     address:
                        name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:C Max Schmidt
               affiliation:
                     name:Indiana University School of Medicine
                     address:
                        name:Department of Surgery, Indiana University School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
                     name:Indiana University School of Medicine
                     address:
                        name:Department of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
                     name:Indiana University School of Medicine
                     address:
                        name:IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jian-Ting Zhang
               affiliation:
                     name:Indiana University School of Medicine
                     address:
                        name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
                     name:Indiana University School of Medicine
                     address:
                        name:IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Role of 14-3-3Οƒ in poor prognosis and in radiation and drug resistance of human pancreatic cancers
      description:Pancreatic cancer is the fourth leading cause of death in the US. Unlike other solid tumors such as testicular cancer which are now curable, more than 90% of pancreatic cancer patients die due to lack of response to therapy. Recently, the level of 14-3-3Οƒ mRNA was found to be increased in pancreatic cancers and this increased expression may contribute to the failure in treatment of pancreatic cancers. In the present study, we tested this hypothesis. Western blot analysis was used to determine 14-3-3Οƒ protein level in fresh frozen tissues and was correlated to clinical outcome. A stable cell line expressing 14-3-3Οƒ was established and the effect of 14-3-3Οƒ over-expression on cellular response to radiation and anticancer drugs were tested using SRB assay and clonogenic assays. Cell cycle distribution and apoptosis analyses were performed using propidium iodide staining and PARP cleavage assays. We found that 14-3-3Οƒ protein level was increased significantly in about 71% (17 of 24) of human pancreatic cancer tissues and that the 14-3-3Οƒ protein level in cancers correlated with lymph node metastasis and poor prognosis. Furthermore, we demonstrated that over-expression of 14-3-3Οƒ in a pancreatic cancer cell line caused resistance to Ξ³-irradiation as well as anticancer drugs by causing resistance to treatment-induced apoptosis and G2/M arrest. The increased level of 14-3-3Οƒ protein likely contributes to the poor clinical outcome of human pancreatic cancers by causing resistance to radiation and anticancer drugs. Thus, 14-3-3Οƒ may serve as a prognosis marker predicting survival of pancreatic cancer patients and guide the clinical treatment of these patients.
      datePublished:2010-11-01T00:00:00Z
      dateModified:2010-11-01T00:00:00Z
      pageStart:1
      pageEnd:11
      license:https://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1471-2407-10-598
      keywords:
         Pancreatic Cancer
         Gemcitabine
         Pancreatic Cancer Cell
         Mitoxantrone
         Human Pancreatic Cancer
         Cancer Research
         Oncology
         Surgical Oncology
         Health Promotion and Disease Prevention
         Biomedicine
         general
         Medicine/Public Health
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-598/MediaObjects/12885_2010_Article_2397_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-598/MediaObjects/12885_2010_Article_2397_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-598/MediaObjects/12885_2010_Article_2397_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-598/MediaObjects/12885_2010_Article_2397_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-598/MediaObjects/12885_2010_Article_2397_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-10-598/MediaObjects/12885_2010_Article_2397_Fig6_HTML.jpg
      isPartOf:
         name:BMC Cancer
         issn:
            1471-2407
         volumeNumber:10
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Zhaomin Li
            affiliation:
                  name:Indiana University School of Medicine
                  address:
                     name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zizheng Dong
            affiliation:
                  name:Indiana University School of Medicine
                  address:
                     name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David Myer
            affiliation:
                  name:Indiana University School of Medicine
                  address:
                     name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michele Yip-Schneider
            affiliation:
                  name:Indiana University School of Medicine
                  address:
                     name:Department of Surgery, Indiana University School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
                  name:Indiana University School of Medicine
                  address:
                     name:IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jianguo Liu
            affiliation:
                  name:Indiana University School of Medicine
                  address:
                     name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ping Cui
            affiliation:
                  name:Indiana University School of Medicine
                  address:
                     name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:C Max Schmidt
            affiliation:
                  name:Indiana University School of Medicine
                  address:
                     name:Department of Surgery, Indiana University School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
                  name:Indiana University School of Medicine
                  address:
                     name:Department of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
                  name:Indiana University School of Medicine
                  address:
                     name:IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jian-Ting Zhang
            affiliation:
                  name:Indiana University School of Medicine
                  address:
                     name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
                  name:Indiana University School of Medicine
                  address:
                     name:IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:BMC Cancer
      issn:
         1471-2407
      volumeNumber:10
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Indiana University School of Medicine
      address:
         name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:Indiana University School of Medicine
      address:
         name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:Indiana University School of Medicine
      address:
         name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:Indiana University School of Medicine
      address:
         name:Department of Surgery, Indiana University School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:Indiana University School of Medicine
      address:
         name:IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:Indiana University School of Medicine
      address:
         name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:Indiana University School of Medicine
      address:
         name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:Indiana University School of Medicine
      address:
         name:Department of Surgery, Indiana University School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:Indiana University School of Medicine
      address:
         name:Department of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:Indiana University School of Medicine
      address:
         name:IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:Indiana University School of Medicine
      address:
         name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
         type:PostalAddress
      name:Indiana University School of Medicine
      address:
         name:IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Zhaomin Li
      affiliation:
            name:Indiana University School of Medicine
            address:
               name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:Zizheng Dong
      affiliation:
            name:Indiana University School of Medicine
            address:
               name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:David Myer
      affiliation:
            name:Indiana University School of Medicine
            address:
               name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:Michele Yip-Schneider
      affiliation:
            name:Indiana University School of Medicine
            address:
               name:Department of Surgery, Indiana University School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
            name:Indiana University School of Medicine
            address:
               name:IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:Jianguo Liu
      affiliation:
            name:Indiana University School of Medicine
            address:
               name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:Ping Cui
      affiliation:
            name:Indiana University School of Medicine
            address:
               name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:C Max Schmidt
      affiliation:
            name:Indiana University School of Medicine
            address:
               name:Department of Surgery, Indiana University School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
            name:Indiana University School of Medicine
            address:
               name:Department of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
            name:Indiana University School of Medicine
            address:
               name:IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:Jian-Ting Zhang
      affiliation:
            name:Indiana University School of Medicine
            address:
               name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
            name:Indiana University School of Medicine
            address:
               name:IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
      name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
      name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
      name:Department of Surgery, Indiana University School of Medicine, Indianapolis, USA
      name:IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA
      name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
      name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
      name:Department of Surgery, Indiana University School of Medicine, Indianapolis, USA
      name:Department of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, USA
      name:IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA
      name:Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, USA
      name:IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA

External Links {πŸ”—}(13)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Prism.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk
3.4s.